ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990